NeurologyWire

Botox Approved for Lower Limb Spasticity

From NeurologyWire

The FDA has approved Botox (onabotulinumtoxinA) for the treatment of lower limb spasticity in adult patients to decrease the severity of increased muscle stiffness in ankle and toe muscles. The approval was based on a large, international development program that included a phase three, multi-center, double-blind, randomized, placebo-controlled cli...

Login to read story

Wednesday, January 06, 2016

Show last days of articles

FDA Grants Breakthrough Status to Niemann-Pick Type C1 Disea...

From NeurologyWire

The FDA has granted Breakthrough Therapy designation status to a drug candidate for the treatment of Niemann-Pick Type C1 Disease (NPC), Breakthrough ...Full story

Tuesday, January 05, 2016

Xeomin Approved for Upper Limb Spasticity in Adults

From NeurologyWire

The FDA has approved Xeomin (incobotulinumtoxinA, Merz North America) for the treatment of upper limb spasticity (ULS) in adult patients. In clinical ...Full story

Hepatitis C Associated with Increased Risk of Parkinsons Dis...

From NeurologyWire

The hepatitis C virus may be associated with an increased risk of developing Parkinsons disease, according to new data published in Neurology. In the ...Full story

Wednesday, December 30, 2015

NeuroDerm Starts Patient Enrollment in Phase II Trial of ND0...

From NeurologyWire

NeuroDerm Ltd. announced the start of patient enrollment in a first efficacy trial of ND0612H, the company's continuously administered subcutaneous le...Full story

Wednesday, December 23, 2015

Investigational Parkinsons Agent Impresses in Phase 3 Trial

From NeurologyWire

Results from the Phase 3 EASE LID clinical trial suggest that the investigational compound ADS-5102 (amantadine HCl) is effective in the treatment of ...Full story

ADT Therapy for Prostate Cancer Tied to Alzheimers Disease

From NeurologyWire

Androgen deprivation therapy (ADT) for the treatment of prostate cancer could increase risk of Alzheimers disease, new data suggests (Journal of Clini...Full story

Friday, December 18, 2015

Brain Injury Association of America Announces the 11th Annua...

From NeurologyWire

The Brain Injury Association of America has announced that New Orleans is the site of its premier brain injury business conference in 2016. The 11th A...Full story

Tuesday, December 15, 2015

Study to Test Effectiveness of App to Track Concussions

From NeurologyWire

Researchers at NYU Langone Medical Center will begin testing whether a new free mobile app for iPhone and Apple Watch can help those with concussions ...Full story

Monday, December 14, 2015

Medtronic and Samsung Partner to Create Android-based Tools ...

From NeurologyWire

Medtronic and Samsung Electronics America are allying to accelerate the development of digital health solutions for patients that may benefit from neu...Full story

Wednesday, December 09, 2015

AES Data: Lacosamide Well Tolerated

From NeurologyWire

Data presented at the 2015 Annual Meeting of the American Epilepsy Society support the use lacosamide (Vimpat, UCB Pharma) as long-term monotherapy tr...Full story

Ischemic Stroke Risk in Young Adults More Pronounced in Afri...

From NeurologyWire

New findings suggest pronounced ethnic differences in ischemic stroke subtypes in young adults. In a new study published in BMC Neurology (October 29,...Full story

New Approvals for Medtronic Systems Allow DBS Patients Great...

From NeurologyWire

Systems within Medtronics Activ portfolio of Deep Brain Stimulation (DBS) neurostimulators have received FDA approval for full-body Magnetic Resonance...Full story

Tuesday, December 08, 2015

Adverse Events and Use of Healthcare Resources More Prevalen...

From NeurologyWire

New data presented at the Annual Meeting of American Epilepsy Society Annual Meeting found there were more adverse outcomes and greater use of healthc...Full story

Wednesday, December 02, 2015

FDA Grants StimRelieve IDE Approval to Investigate Wireless ...

From NeurologyWire

StimRelieve has received FDA Investigational Device Exemption (IDE) approval to launch a clinical trial of its percutaneously implantable device for t...Full story

Monday, November 23, 2015

Gene Discovered to Play a Role in Development of MS

From NeurologyWire

New findings point to a role for FAM126A (also known as hyccin) in supporting myelination, an important process in development and also following acut...Full story